Key result
Non-alcoholic fatty liver disease was associated with a significantly higher incidence of triple vessel disease (80.87% vs 9.7%) in patients undergoing coronary artery bypass graft surgery.
Why the study?
Is non-alcoholic fatty liver disease associated with more severe ischemic heart disease in patients undergoing CABG?
Cross-Sectional (n=135)
No
Is non-alcoholic fatty liver disease associated with more severe ischemic heart disease in patients undergoing CABG?
Absolute Event Rate: 80.87% vs 9.7%
Non-alcoholic fatty liver disease is strongly correlated with more severe angiographic coronary artery disease, including triple vessel and left main stem disease, in patients undergoing CABG.
Objectives: To find the correlation between the non-alcoholic fatty liver disease(NFALD) and ischemic heart disease. Study Design: Retrospective cross-sectional study.Period: May 2014 to Nov 2014. Setting: CPE Institute of Cardiology. Material and methods:One hundred and thirty five participants were incorporated in the study. In Group I; patientswere with NAFLD and in group II; patients were without NAFLD. Data was Analyzed using SPSSV20 software. Results: Mean age in NAFLD group was 52.0+02.6 years and in without NAFLD53.0+1.89 years. There were 73.2 % males in NAFLD group. Incidence of Family history anddiabetes was higher in NAFLD group. The incidence of carotid artery stenosis was 4 (9.7%) inNAFLD group versus 6 (6.3%) in without NAFLD group. we also found a significantly higherincidence of triple vessel and left main stem disease in NAFLD group, it was 34 (80.87%) and3 (7.31%) in NAFLD group versus 9 (9.7%) and 2 (2.12%) in without NALD group respectively.Conclusion: Non-alcoholic Fatty liver Disease has a strong correlation with ischemic heartdisease.
No takes yet. Share an insight, caveat, or question.
Khalid et al. (2016) conducted a cross-sectional in Ischemic Heart Disease (n=135). Non-alcoholic fatty liver disease (NAFLD) vs. Without NAFLD was evaluated on Incidence of triple vessel disease. Non-alcoholic fatty liver disease was associated with a significantly higher incidence of triple vessel disease (80.87% vs 9.7%) in patients undergoing coronary artery bypass graft surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: